Veterans News

  1. Home
  2. News
  3. Veterans News

Hyperbaric Oxygen Therapy (HBOT) News for Veterans

Local doctor continues to push VA to approve Hyperbaric Oxygen Therapy for veterans

The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.

read more
Dying for a cure

Dying for a cure

CINCINNATI (WKRC) - Suicide among our members of the military and our veterans is now at its highest level ever, reaching an average of 24 deaths a day. Several scientific and medical studies link many of these suicides to physical brain damage suffered by combat...

read more

2018 – A Year’s Worth of HBOT Progress

The last year has seen unprecedented progress with respect to getting the DOD/VA/Army and general medicine moving forward in recognizing that Hyperbaric Oxygen Therapy (HBOT) is safe, dramatically more effective, and much less expensive than all other...

read more

Could hyperbaric treatment heal the brain?

Each year, thousands of Americans suffer a traumatic brain injury. In 2013, about 2.8 million TBI-related emergency department visits, hospitalizations and deaths occurred in the United States, according to the Centers for Disease Control and Prevention. Most of these...

read more